Our Archive
3 Rivers Biotech (“3 Rivers“ or the “Company”), a leader in plant tissue culture propagation, pathogen testing and genetic fingerprinting in the cannabis, hemp and traditional agriculture sectors, is pleased to announce that it has appointed Prof. Dr. Zamir Punja to its Advisory Board.
Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”) today announced that the Company has entered into a binding terms sheet concerning a joint venture (JV) partnership with 3 Rivers Biotech Inc. (“3 Rivers”), a leading agricultural technology company specialized in commercial scale micropropagation, or plant tissue culture (PTC), for cannabis, hemp and traditional crops.
3 Rivers Biotech today announced the opening of its Genetic Centre of Excellence (“Genie Lab”). This facility provides genetic fingerprinting, as well as tests for pathogenic viruses and fungi specific to cannabis and hemp.
3 Rivers will leverage its network of suppliers to and manufacturers of Consumer Packaged Goods (CPG) to secure commercial partnerships based on CTT’s patented sublingual wafer technology
3 Rivers will sell tissue culture clones derived from Hemp Mine’s premium hemp varieties to licensed growers across the United States and globall
3 Rivers will initiate two of Cheyenne’s top performing varieties, Mountain Mango and Quick Kush, into tissue culture for the purposes of manufacturing and selling micropropagated hemp plants to licensed growers across the United States
Under the terms of the agreement 3 Rivers will initiate, micropropagate, and sell some of Trilogene’s premium hemp varieties to licensed growers across the United States
The Mount Vernon facility comprises a 14,000 sqft tissue culture lab and 40,000 sqft of attached propagation greenhouses, with a combined production output of up to 12 million plants per year
Recent Comments